'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive
Clover Health Investments Corp CLOV
$4.17
▼ -3.92%
($-0.17)
🎢 High Beta
📅 Earnings This Week
Open
$4.35
Prev Close
$4.34
Day Range
$4.16 – $4.35
52W Range
$1.58 – $5.59
Market Cap
$2.20B
Beta
2.52
EPS (TTM)
$-0.11
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-06-12 |
| Shares Out. | 526,680,000 |
| Website | cloverhealth.com/ ↗ |
| Phone | 12014322133 |
| Employees | 724 |
| Revenue | $749.2M |
| Gross Profit | $159.5M |
| Net Income | $27.3M |
| Free Cash Flow | $54.5M |
| Total Assets | $697.7M |
| Total Liabilities | $358.3M |
| Equity | $339.4M |
About Clover Health Investments Corp
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Clover Health Investments Corp is a publicly traded company under the ticker symbol CLOV on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)